Maroney Dawn Christine 4

What Happened Dawn Maroney, President of Alignment Healthcare, sold a total of 29,113 shares in two transactions on March 12, 2026. The larger sale was 27,350 shares reported at a weighted-average price of $17.48 (reported value $477,969); the smaller sale was 1,763 shares at a weighted-average price of $16.99 (reported value $29,957). Total proceeds were approximately $507,926. These were sales (S) and, per the filing footnote, were executed to satisfy tax withholding obligations tied to the vesting of restricted stock units — not discretionary market trades.

Key Details

• Transaction dates: March 12, 2026 (reported on March 13, 2026) — filing appears timely.
• Prices reported: weighted averages $17.48 (range $17.035–$18.03) and $16.99 (range $16.92–$17.03). Full per-price breakdowns are available on request per the footnotes.
• Shares sold: 27,350 and 1,763 (total 29,113). Total proceeds ≈ $507,926.
• Reason/footnote: F1 indicates these shares were sold to cover tax withholding for RSU vesting (not a discretionary sale). F2 and F3 note the reported prices are weighted averages across multiple trades.
• Shares owned after transaction: not disclosed in the provided excerpt of the filing.
• Transaction code: S = Sale; this is a routine tax-withholding disposition rather than a purchase signal.

Context Sales to cover tax withholding when RSUs vest are common and typically do not signal a change in an insider’s view of the company. Retail investors often weigh purchases by insiders more heavily as potential bullish signals; in this case the filing documents a non-discretionary, tax-related sale.